Biocon jumps 10% in two days after strong Q2 results; brokerages see up to 18% upside ahead; check price target

Biocon Share Price: Solid earnings, robust biosimilars growth, and improving margins drive renewed optimism; analysts see double-digit upside potential in the stock.